diagnostic radiology News
-
VIDEO: Integrating Artificial Intelligence Into Radiologists Workflow
Artificial Intelligence (AI) is becoming more common place in radiology practices, and emerging technologies are providing radiologists with sophisticated detection software to aid their reading and provide support for a busy workflow. With the progression of AI technology, vendors must look not only at what AI can do for the radiologist, but how the radiologist and the technician interact ...
-
VIDA, UnityPoint Health join forces to modernize lung and respiratory care with agreement to implement AI-powered lung intelligence solutions across the UnityPoint Health system
VIDA Diagnostics, Inc. (“VIDA”), the leader in lung and respiratory intelligence, announced today that it has signed an agreement with UnityPoint Health to implement VIDA’s AI-powered lung intelligence and imaging solutions across the UnityPoint Health system. UnityPoint Health is one of the nation’s leading integrated delivery networks, with 21 hospitals and more than ...
-
Nanox and USARAD Introduce Radiology AI Second Opinion Program
NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announces an extension of its strategic collaboration with USARAD Holdings Inc., a US Joint Commission accredited teleradiology and telemedicine company, to launch an advanced radiology diagnostics service combining over 300 expert radiologists and ...
-
Queen’s University Radiology Receives Hyperfine Portable MRI to Improve Access to Care for Canadian Patients in Remote Northern Communities
Hyperfine, Inc. (Nasdaq:HYPR), creator of Swoop®, the first FDA-cleared portable magnetic resonance imaging (MRI) system™, is proud to announce that Queen’s University and Kingston Health Sciences Centre are deploying a Swoop system as part of their health services benefitting six communities located in the James Bay and Hudson Bay Area. Until now, patients needing routine or ...
By Hyperfine
-
Profound Medical and Akumin Enter into U.S. Multi-Center Commercial Agreement for TULSA-PRO
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced the signing of a multi-site imaging center agreement for TULSA-PRO® with Akumin Inc. (NASDAQ/TSX:AKU) (“Akumin”), a leading ...
-
FDA Approves Breath Test To Aid In Diagnosis Of Delayed Gastric Emptying
The U.S. Food and Drug Administration today approved the Gastric Emptying Breath Test (GEBT), a new non-invasive test to aid in the diagnosis of delayed gastric emptying, known as gastroparesis. Current tests used to diagnose gastroparesis typically involve the use of a small amount of radioactive material or imaging equipment, so testing must be conducted in specialized outpatient centers. ...
-
Shockwave IVL Maintains Superiority to Angioplasty in Calcified Peripheral Disease at Two Years
Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that long-term data from the Disrupt PAD III trial found that superior vessel preparation with IVL led to excellent long-term outcomes out to two years with preservation of future treatment options compared to percutaneous ...
-
New Research Shows CureMetrix AI More Accurately Flags Anomalies in Mammograms and Improves Turnaround Time
New research finds that artificial intelligence (AI) by CureMetrix, Inc., a global healthcare technology company that develops AI-driven software for radiology, can greatly improve turnaround time for mammogram results and more accurately flag anomalies in a mammogram. The Journal of the American College of Radiology (JACR) has published a case study documenting the two-year, in-practice clinical ...
-
Radiology partners selects Aidoc to Accelerate the use of AI as the standard of Care in Radiology
Radiology Partners (RP), the leading radiology practice in the U.S., announced today that it has selected Aidoc, the leading provider of artificial intelligence (AI) solutions for medical imaging, to offer unparalleled AI capabilities to its hospitals and health systems, and to accelerate the adoption of AI as the standard of care in radiology. “AI has the potential to unlock enormous ...
By Aidoc
-
QView Medical Inc. Announces FDA PMA Approval for QVCAD for the GE Invenia 3D Automated Breast Ultrasound System (“ABUS”)
QView Medical is pleased to announce FDA approval for QVCAD to be used with the GE Invenia™ ABUS in breast screening for asymptomatic dense breasted women whose mammogram was negative. QVCAD is the next generation CAD system for automated breast ultrasound ("ABUS") based on deep learning algorithms. The QVCAD innovative C-Thru technology combined with ABUS has demonstrated a 33% improved ...
-
New Findings Show AI Software Improves Breast Cancer Detection and Physician Accuracy
A New York City based large volume private practice radiology group conducted a quality assurance review that included an 18 month software evaluation in the breast center comprised of nine (9) specialist radiologists using an FDA cleared artificial intelligence software by Koios Medical, Inc as a second opinion for analyzing and assessing lesions found during breast ultrasound examinations. ...
-
European Radiology Profiles Seno Medical’s Ground-Breaking Breast Cancer Diagnostic Technology
Additional research appearing in the June online issue (open access) of European Radiology features the groundbreaking diagnostic breast cancer imaging technology introduced by Seno Medical Instruments™, Inc. (Seno Medical). This technology might not only help physicians better differentiate between benign and malignant breast lesions, but also discriminate between breast cancer molecular ...
-
Blue Earth Diagnostics Appoints Dr. David E. Gauden as Chief Executive Officer and Dr. Eugene J. Teoh as Chief Medical Officer
Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced the appointment of David E. Gauden, D.Phil. as its new Chief Executive Officer (CEO). Former CEO and Executive Chairman Jonathan Allis, D.Phil., assumes the role of Honorary Chairman of the Blue Earth Diagnostics Board of Directors. Dr. ...
-
Bayer driving innovation in radiology with new research across the portfolio presented at ECR
Featured presentations include development compound gadoquatrane, a novel contrast agent for MRI Further research explores potential of AI and digital advances in medical imaging Bayer announced today that new data from the company’s advanced radiology portfolio will be presented at the 2023 European Congress of Radiology (ECR), taking place from March 1-5 in Vienna, Austria. The ...
By Bayer AG
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you